Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination

American Journal of Medical Genetics

Volumn 120 A, Issue 3, 2003, Pages 359-364

  Armstrong, Katrina ^a   Weber, Barbara ^b   FitzGerald, Genevieve ^b   Hershey, John C ^b   Pauly, Mark V ^b   Lemaire, Jean ^b   Subramanian, Krupa ^b   Asch, David A ^b  

^a MSCE   (United States)

^b NONE

Author keywords

BRCA1; Genetic screening; Insurance selection bias

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; GENE MUTATION; GENETIC COUNSELING; HEALTH INSURANCE; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0042825231     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.20025     Document Type: Article

References (24)

1. American Council of Life Insurance. 1996. Life insurance fact book. Washington, DC: American Council of Life Insurance.
2. Armstrong K, Eisen A, Weber BL. 2000. Assessing the risk of breast cancer. N Engl J Med 324:564-571.
3. Berger LA, Cummins JD. 1991. Adverse selection and equilibrium in liability insurance markets. Philadelphia, PA: Center for Research on Risk and Insurance, Wharton School of the University of Pennsylvania.
4. Black K, Skipper HD. 1994. Life insurance. 12th edition. Englewood Cliffs, NJ: Prentice Hall.
5. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A. 1994. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258-261.
6. Claus EB, Risch N, Thompson WD. 1994. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643-651.
7. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium. 1995. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271.
8. Fisher B, Constantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. 1998. Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388.
9. Gostin L. 1991. Genetic discrimination: The use of genetically based diagnostic and prognostic tests by employers and insurance. Am J Law Med 17:109-144.
10. Hartwell KW. 1988. Measuring life insurance profitability in today's environment. Atlanta, Georgia: Life Office Management Association.
11. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL. 1995. Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. JAMA 273:577-585.
12. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D. 1991. Identification of FAP locus genes from chromosome 5q21. Science 253:661-665.
13. Lemaire J, Subramanian K, Armstrong K, Asch DA. 2000. Pricing term insurance in the presence of a family history ofbreast or ovarian cancer. N Am Actuarial J 4:75-87.
14. McEwen JE, McCarty K, Reilly PR. 1993. A survey of medical directors oflife insurance companies concerning use of genetic information. Am J Hum Genet 53:33-45.
15. McEwen JE, Reilly PR. 1992. State legislative efforts to regulate use and potential misuse of genetic information. Am J Hum Genet 51:637-647.
16. Meijers-Heijboer H, van Geel B, van Putten W LJ, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers M BE, Bartels C CM, Verhoog LC, van den Ouweland A MW, Niermeijer MF, Brekelmans C TM, Klijn J GM. 2001. Breast cancer after prophylactic bilateral mastectomy in women with a BRCAI or BRCA2 mutation. N Engl J Med 345:159-164.
17. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-710.
18. Natowicz MR, Alper JK, Alper JS. 1992. Genetic discrimination and the law. Am J Hum Genet 50:465-475.
19. Ostrer H, Allen W, Crandall LA, Moseley RE, Dewar MA, Nye D, McCrary SV. 1993. Insurance and genetic testing: Where are we now? Am J Hum Genet 52:565-577.
20. Schmidt F. 1996. Aetna official presents case for genetic testing to NAIC. Natl Underwrit [Life Health] 100:8.
21. Subramanian K, Lemaire J, Hershey JC, Pauly MV, Armstrong K, Asch DA. 1999. Estimating adverse selection costs from genetic testing for breast and ovarian cancer: The case of life insurance. J Risk Insur 66:531-550.
22. Wilcox W. 1997. Health insurance source book. Detroit, MI: Omnigraphics.
23. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
24. Zick CD, Smith KR, Mayer RN, Botkin JR. 2000. Genetic testing, adverse selection and the demand for life insurance. Am J Med Genet 93:29-39.